Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Study Classification

INTERVENTIONAL

Study Start Date

2004-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the effect of erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Randomized Study of the Use of Intravenous Choline Supplementation in Long Term Total Parenteral Nutrition

NCT00004697

Fatty Liver

COMPLETED NA

Early Enteral Nutrition for Severe Acute Pancreatitis

NCT00995098

Acute Necrotizing Pancreatitis

COMPLETED PHASE4

Total Parenteral Nutrition-Associated Liver Disease

NCT00031135

Liver Diseases

TERMINATED PHASE2

Study of Bile Acids in Patients With Peroxisomal Disorders

NCT00004442

Infantile Refsum's Disease Zellweger Syndrome Bifunctional Enzyme Deficiency +1 more

TERMINATED NA

A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis

NCT03345589

Primary Biliary Cholangitis

UNKNOWN PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erythromycin

Group Type EXPERIMENTAL

Erythromycin

Intervention Type DRUG

Subjects receive 4x250mg erythromycin i.v. daily after intubation of a self-propelled feeding tube

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Subjects receive 4x placebo i.v. daily after intubation of a self-propelled feeding tube

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erythromycin

Subjects receive 4x250mg erythromycin i.v. daily after intubation of a self-propelled feeding tube

Intervention Type DRUG

Placebo

Subjects receive 4x placebo i.v. daily after intubation of a self-propelled feeding tube

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18-80 years
* Having pancreatitis
* Require jejunal enteral nutrition

Exclusion Criteria

* Known impaired peristalsis (critically ill patients, postoperative patients, history of surgery of the stomach/duodenum)
* Pregnancy
* Hypersensibility to erythromycin
* Cardiac arrhythmias with a prolonged QT-time
* Simultaneous usage of drugs impairing peristalsis

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No